Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 21 04:00PM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-1.49 Insider Own39.23% Shs Outstand35.97M Perf Week-15.00%
Market Cap137.89M Forward P/E- EPS next Y-0.73 Insider Trans0.00% Shs Float21.91M Perf Month-16.30%
Income-57.71M PEG- EPS next Q-0.41 Inst Own56.75% Short Float22.10% Perf Quarter-31.45%
Sales17.63M P/S7.82 EPS this Y-3.44% Inst Trans-10.03% Short Ratio21.60 Perf Half Y-27.14%
Book/sh0.68 P/B5.61 EPS next Y49.98% ROA-56.07% Short Interest4.84M Perf Year-65.85%
Cash/sh1.62 P/C2.36 EPS next 5Y- ROE-114.99% 52W Range4.01 - 11.75 Perf YTD-39.00%
Dividend Est.- P/FCF- EPS past 5Y2.15% ROI-88.53% 52W High-67.45% Beta0.07
Dividend TTM- Quick Ratio5.44 Sales past 5Y0.00% Gross Margin69.24% 52W Low-4.60% ATR (14)0.34
Dividend Ex-Date- Current Ratio6.21 EPS Y/Y TTM-12.90% Oper. Margin-338.58% RSI (14)33.65 Volatility11.64% 7.30%
Employees136 Debt/Eq1.66 Sales Y/Y TTM754.68% Profit Margin-327.29% Recom1.33 Target Price19.50
Option/ShortYes / Yes LT Debt/Eq1.65 EPS Q/Q-22.12% Payout- Rel Volume1.10 Prev Close4.04
Sales Surprise2.09% EPS Surprise17.56% Sales Q/Q195.78% EarningsMay 14 AMC Avg Volume224.07K Price3.83
SMA20-16.40% SMA50-21.26% SMA200-34.66% Trades Volume246,350 Change-5.32%
Date Action Analyst Rating Change Price Target Change
Sep-07-23Initiated Craig Hallum Buy $20
Dec-01-22Initiated Cowen Outperform $25
Oct-21-22Resumed Jefferies Buy $14
Oct-11-22Upgrade SVB Leerink Mkt Perform → Outperform $11
Aug-02-22Initiated Maxim Group Buy $10
Sep-09-21Initiated SVB Leerink Mkt Perform $6
Oct-15-19Initiated H.C. Wainwright Buy $13
Jan-30-19Downgrade Leerink Partners Outperform → Mkt Perform
May-15-24 11:44AM
May-14-24 08:56PM
04:01PM Loading…
May-13-24 04:05PM
May-07-24 04:05PM
Apr-24-24 08:00AM
Mar-16-24 03:57PM
Mar-13-24 05:33PM
Mar-06-24 04:01PM
Feb-28-24 04:01PM
Jan-04-24 04:05PM
01:02PM Loading…
Nov-09-23 01:02PM
Nov-08-23 04:01PM
Nov-01-23 04:05PM
Oct-31-23 08:00AM
Oct-05-23 08:00AM
Sep-19-23 08:00AM
Sep-05-23 08:00AM
Aug-10-23 05:40PM
Aug-03-23 08:00AM
Aug-01-23 08:00AM
Jul-19-23 08:00AM
Jun-23-23 08:00AM
May-31-23 08:00AM
May-13-23 12:39PM
06:03AM Loading…
May-12-23 06:03AM
May-10-23 05:15PM
May-02-23 08:00AM
Mar-27-23 07:12AM
Mar-24-23 06:16AM
Mar-22-23 04:05PM
Mar-15-23 08:00AM
Feb-23-23 08:00AM
Feb-21-23 08:00AM
Feb-06-23 08:00AM
Jan-31-23 08:00AM
Jan-30-23 08:00AM
Jan-10-23 05:37AM
Dec-29-22 06:47PM
Dec-20-22 12:00PM
Dec-19-22 08:00AM
Dec-14-22 08:00AM
Nov-22-22 08:01AM
Nov-21-22 04:01PM
Nov-09-22 04:30PM
Nov-02-22 08:00AM
Oct-26-22 08:00AM
Oct-11-22 05:32PM
Oct-10-22 09:41AM
Sep-30-22 08:00AM
Sep-01-22 08:00AM
Aug-09-22 07:00AM
Jul-31-22 08:22AM
Jul-13-22 08:00AM
Jul-12-22 08:00AM
Jun-30-22 08:00AM
Jun-07-22 08:00AM
May-24-22 08:00AM
May-17-22 08:00AM
May-16-22 07:10AM
Apr-11-22 07:00AM
Mar-22-22 07:00AM
Mar-01-22 04:05PM
Feb-21-22 09:06AM
Feb-16-22 04:05PM
Feb-03-22 08:00AM
Dec-20-21 04:05PM
Nov-22-21 08:39AM
Nov-09-21 07:00AM
Nov-02-21 08:30AM
Sep-10-21 08:00AM
Sep-01-21 08:00AM
Aug-23-21 10:52AM
Aug-11-21 07:00AM
Jul-13-21 04:08PM
Jul-01-21 08:00AM
May-19-21 08:00AM
May-12-21 08:00AM
Mar-23-21 07:00AM
Feb-25-21 08:00AM
Feb-24-21 03:23AM
Feb-23-21 11:03AM
Feb-17-21 08:00AM
Feb-11-21 08:00AM
Dec-11-20 08:49PM
Dec-10-20 02:18AM
Dec-08-20 12:45PM
scPharmaceuticals, Inc. engages in the development of transformative pharmaceutical products for subcutaneous delivery. Its products include FUROSCIX, a furosemide injection which is used as parenteral diuretic in treating heart failure and scCeftriaxone, used as parenteral antibiotic outside the hospital setting. The company was founded by Pieter Muntendam and Bertram Pitt in February 2013 and is headquartered in Burlington, MA.